Free Submission Public Relations & NewsPR-inside.com
 
DeutschEnglish

Get the latest news
with our RSS feed
rss feed
Add to My Yahoo!
More information
Business

Cytori to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference


Print article Print article
Refer this article Refer to a friend
© Business Wire 2008
2008-05-12 23:47:02 -

- Cytori Therapeutics, Inc. (NASDAQ: CYTX) will present and provide an audio webcast of its corporate presentation at the Rodman & Renshaw 5th Annual Global Healthcare Conference in Monte Carlo, Monaco on May 19, 2008 at 3:40 A.M. Eastern Daylight Time.

The audio webcast may be accessed under "Events & Webcasts" in the Investor Relations section of the Company's

website at www.cytoritx.com. The webcast will be available live and by replay one hour after the presentation on the company's website and archived for 90 days.

About Cytori

Cytori's (NASDAQ: CYTX) goal is to be the global leader in regenerative medicine. The company is dedicated to providing patients with new options for reconstructive surgery, developing treatments for cardiovascular disease, and banking patients' adult stem and regenerative cells. The Celution(R) 800 System is being introduced in Europe into the reconstructive surgery market while the Celution(R) 900 System will be launched in Asia-Pacific for cryopreserving a patient's own stem and regenerative cells. Clinical trials are ongoing in cardiovascular disease and planned for spinal disc degeneration, gastrointestinal disorders, and other unmet medical needs. www.cytoritx.com

Cytori Therapeutics, Inc.
Tom Baker, 858-875-5258
tbaker@cytoritx.com


Disclaimer: (c) 2007 Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.


Terms & Conditions | About us | Contact PR-inside.com